Examinando por Autor "Stach, Michael"

Mostrando 1 - 1 de 1
  • Miniatura
    Ítem
    Study protocol of the e-Intervention Enhancing Mental Health in Adolescents (IMPROVA) project: a randomised controlled trial to promote adolescents' mental health and well-being in four European countries
    (2026-04-28) Antunes, Rodrigo; Baumeister, Harald; Pryss, Rüdiger; Küchler, Ann-Marie; Kraft, Robin; Berghoff, Nils; Nagel, Luzia; Reichert, Manfred; Idrees, Abdul Rahman; Stach, Michael; Melchior, Maria; Davisse-Paturet, Camille; Falkiner, Emma; van der Waerden, Judith; Baban, Adriana; Taut, Diana; Danila, Ingrid; Perez Anton, Mariona; Porricelli, Daniele; Sanguesa, Julia; Moneta, María Victoria; García Carrión, Rocío ; Finkenauer, Catrin; Gonneke Stevens; Krabbendam, Lydia; Bolinski, Felix; Maresova, Petra; Nilsen, Per; Karlsson, Nadine; Moreno, Natalia; Le Corvec, Anaïs; Haro, Josep Maria
    INTRODUCTION: This trial aims to evaluate the impact of the IMPROVA intervention programme in improving mental health, quality of life, and well-being in adolescents enrolled in secondary schools in four European countries. METHODS AND ANALYSIS: The IMPROVA intervention will be evaluated using a two-arm parallel group pragmatic cluster randomised controlled trial with an intervention and a wait-list control group. Secondary schools in France, Germany, Romania, and Spain were recruited. Originally, we estimated to enrol a total of 6000 students within 64 schools; that is, 16 schools per country. The IMPROVA programme is a multi-level intervention that provides tailored content for adolescents, families, and school staff. This content creates a unified and supportive framework that promotes mental health and social-emotional development among adolescents. A series of implementation strategies was planned to support the uptake of the programme into the education setting and among participants. Study outcomes were assessed at baseline, mid-term (during the intervention), postintervention (primary end point), and will be assessed at postintervention (secondary end-point; 6 months after postintervention). Overall mental health (Strengths and Difficulties Questionnaire) is the primary outcome. Secondary outcomes include: health-related quality of life, depression, anxiety, social isolation, and self-esteem. The trial will be evaluated regarding its effectiveness, cost-effectiveness, implementation, and social return on investment analysis. ETHICS AND DISSEMINATION: This study has received the approval of human research ethics committees in France (Comité de Protection des Personnes Ile-de-France VIII", No. 2024-A00201-46), Germany (Ulm University Ethics Committee, No. 186-24), Romania (The Research Ethics Subcommittee of the Babeș-Bolyai University of Cluj-Napoca, No. 14.146/23.09.2024), and Spain (CEIm Fundació Sant Joan de Déu, No. PIC-61-24). Results will be disseminated through peer-reviewed open-access publications and presentations at national and international conferences. Non-technical summaries will be shared with public health authorities, participants, and stakeholder organisations. All findings will be reported in aggregate form, ensuring no individual participant can be identified.